Dexamethasone: All we know about the new COVID-19 ‘breakthrough drug’


As world leaders are invested in finding a vaccine for the coronavirus that has shaken the world to its core, more and more people have expressed hope for the vaccine to come in soon. However, recent developments have set in hope for the world with the introduction of Dexamethasone.

Following the announcement by the World Health Organisation (WHO), a clinically tested drug, Dexamethasone, has proven effective in the fight against coronavirus for those who are critically ill. They also shared a little insight on the nature, effect, and cost of the drug.

One major thing to take note is how cheap the drugs are. However, many people have shared their takes on the updates as many shared their happiness and others; their reservations on the announcement of the breakthrough.

For many, while this is a major breakthrough, they still stressed out the possibility of internal crisis that may arise as they stressed that the drug will be hoarded and made expensive in the end. Some countries are, however, yet to adopt the use of this drug as a treatment process for coronavirus patients.

As shared on the report by the World Health Organization, the drug is not to be taken by patients with mild symptoms as it would prove harmful to them when they take it, the dexamethasone is only to be taken by patients with extreme conditions.

Here’s what we know about Dexamethasone…

Dexamethasone is a type of corticosteroid medication. It is used in the treatment conditions ranging from rheumatic problems, a number of skin diseases, severe allergies, asthma, chronic obstructive lung disease, croup, brain swelling, eye pain following eye surgery, and alongside antibiotics in treating tuberculosis.

Being a steroid that has been used since the 1960s to reduce inflammation in a range of conditions, the drug has been listed on the WHO Model List of Essential Medicines since 1977 in multiple formulations and is currently off-patent and affordably available in most countries.

Leave a reply

Your email address will not be published. Required fields are marked *

cool good eh love2 cute confused notgood numb disgusting fail